MedPacto, Inc. (KOSDAQ:235980)
5,170.00
+40.00 (0.78%)
Apr 10, 2026, 3:30 PM KST
MedPacto Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 11,997 | 15,009 | 72,604 | 359.85 | 1,293 |
Short-Term Investments | 28,701 | 40,469 | - | 96,594 | 120,280 |
Cash & Short-Term Investments | 40,699 | 55,479 | 72,604 | 96,954 | 121,573 |
Cash Growth | -26.64% | -23.59% | -25.11% | -20.25% | 168.36% |
Accounts Receivable | 1,641 | -0 | 0 | 0 | 0 |
Other Receivables | 195.08 | 382.62 | 844.27 | 1,799 | 393.13 |
Receivables | 2,425 | 382.62 | 844.27 | 1,799 | 393.13 |
Inventory | 646.15 | - | - | - | - |
Prepaid Expenses | 50.81 | 50.37 | 99.2 | 351.64 | 381.67 |
Other Current Assets | 1,146 | 878.26 | 1,607 | 1,226 | 3,738 |
Total Current Assets | 44,967 | 56,790 | 75,154 | 100,331 | 126,085 |
Property, Plant & Equipment | 2,412 | 2,789 | 3,647 | 5,203 | 2,563 |
Long-Term Investments | - | 224.28 | 626.12 | 994.75 | 3,384 |
Other Intangible Assets | 595.27 | 228.37 | 343.13 | 438.24 | 565.62 |
Long-Term Accounts Receivable | 42.54 | 0 | 0 | 0 | 0 |
Other Long-Term Assets | 646.66 | 753.59 | 704.17 | 719.86 | 747.06 |
Total Assets | 48,663 | 60,785 | 80,474 | 107,687 | 133,346 |
Accounts Payable | 73.35 | - | - | - | - |
Accrued Expenses | 193.12 | 190.98 | 182.83 | 237.49 | 230.18 |
Short-Term Debt | - | - | - | 60,264 | - |
Current Portion of Leases | 599.1 | 460.78 | 740.54 | 689.06 | 190.17 |
Other Current Liabilities | 502.94 | 723.61 | 641.5 | 5,432 | 557.4 |
Total Current Liabilities | 1,369 | 1,375 | 1,565 | 66,623 | 977.75 |
Long-Term Debt | - | - | - | - | 75,413 |
Long-Term Leases | 1,126 | 1,480 | 1,687 | 2,423 | - |
Other Long-Term Liabilities | 186.47 | 186.55 | 137.28 | 142.18 | 13,413 |
Total Liabilities | 2,681 | 3,042 | 3,389 | 69,188 | 89,803 |
Common Stock | 17,138 | 17,138 | 16,790 | 10,540 | 10,258 |
Additional Paid-In Capital | 240,612 | 239,555 | 233,030 | 165,396 | 141,372 |
Retained Earnings | -212,105 | -199,294 | -179,154 | -143,829 | -108,076 |
Comprehensive Income & Other | 337.87 | 345.38 | 242.42 | 215.57 | -11.16 |
Total Common Equity | 45,982 | 57,743 | 70,909 | 32,323 | 43,543 |
Shareholders' Equity | 45,982 | 57,743 | 77,085 | 38,499 | 43,543 |
Total Liabilities & Equity | 48,663 | 60,785 | 80,474 | 107,687 | 133,346 |
Total Debt | 1,725 | 1,941 | 2,427 | 63,377 | 75,603 |
Net Cash (Debt) | 38,973 | 53,538 | 70,177 | 33,577 | 45,970 |
Net Cash Growth | -27.20% | -23.71% | 109.00% | -26.96% | 2.47% |
Net Cash Per Share | 1137.79 | 1589.63 | 3307.46 | 1009.58 | 2245.36 |
Filing Date Shares Outstanding | 34.19 | 34.28 | 33.58 | 21.08 | 20.52 |
Total Common Shares Outstanding | 34.19 | 34.28 | 33.58 | 21.08 | 20.52 |
Working Capital | 43,598 | 55,415 | 73,589 | 33,708 | 125,108 |
Book Value Per Share | 1344.96 | 1684.70 | 2111.59 | 1533.28 | 2122.33 |
Tangible Book Value | 45,387 | 57,515 | 70,566 | 31,884 | 42,977 |
Tangible Book Value Per Share | 1327.55 | 1678.04 | 2101.37 | 1512.49 | 2094.77 |
Machinery | 4,297 | 1,053 | 1,244 | 3,799 | 2,914 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.